EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitDelphi-Studie

An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice

Luis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, Daniel Q Huang, Cynthia Hsu, Brian P Lee, Alexandre Louvet, Maja Thiele, Federica Tavaglione, Monica Tincopa, Elisa Pose, Leon A Adams und 16 weitere

Clinical Gastroenterology and Hepatology · 2026-03 · 24 (3) · 633-645.e4

DOI: 10.1016/j.cgh.2025.02.017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-03. Verfasst von Luis Antonio Diaz und 27 weiteren Autor:innen. Beteiligte Einrichtung: MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California; Departamento de Gastro…. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Metabolic Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Commission for Scientific and Technological Research National Fund for Scientific and Technological Development, National Institute for Health Research Imperial Biomedical Research Centre, UK Research and Innovation Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Metabolic dysfunction- and alcohol-associated liver disease (MetALD) is a recently defined entity for individuals with liver steatosis, metabolic dysfunction, and increased alcohol intake. However, the current definition of MetALD poses multiple challenges in clinical practice and research. In this Delphi consensus, we provide practical recommendations for the clinical assessment and management of MetALD to address current clinical challenges in MetALD. METHODS: We used a modified Delphi process, including 2 surveys involving a panel of 28 experts from 10 countries spanning 4 continents. We predefined consensus as requiring an ≥80% agreement. RESULTS: The panel reached consensus on 28 statements. Recommendations emphasize the importance of a comprehensive assessment of patients with presumed MetALD, including the quantification of alcohol intake using validated questionnaires and the use of objective biomarkers of alcohol use, such as phosphatidylethanol. The need to reassess metabolic risk factors and liver disease after a period of alcohol abstinence was highlighted to distinguish the primary driver of liver injury. Noninvasive tests were recommended to assess liver disease severity, whereas routine liver biopsy was deemed unnecessary unless other diagnoses were suspected. Comprehensive management strategies should involve multidisciplinary care focusing on lifestyle modifications, alcohol reduction or cessation, weight loss, and exercise. Finally, the panel identified significant gaps in knowledge, advocating for standardized research protocols, longitudinal studies, exploration of pathophysiological mechanisms to inform precision medicine approaches, and the validation of quantitative alcohol biomarkers for identifying MetALD. CONCLUSIONS: This Delphi consensus provides clear recommendations for the clinical assessment and management of MetALD, addressing the unique challenges posed by this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Diseases, AlcoholicMetabolic DiseasesHumansDelphi TechniqueConsensusAlcohol DrinkingSurveys and Questionnaires

Stichwörter der Autor:innen

Alcohol-related Liver DiseaseMASLDMetabolic Dysfunction-associated Steatotic Liver DiseaseNAFLDNon-alcoholic Fatty Liver Disease

Autor:innen und Institutionen

  • MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de C…
  • MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California.
  • Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commo…
  • Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Si…
  • Division of Gastroenterology and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California; Institute for Addiction Science, University of Southern California, Los Angeles, Calif…
  • Service des Maladies de l'Appareil Digestif, University Hospital of Lille, Lille, France; Unité INSERM Infinite, Lille, France.

Förderung

  • National Commission for Scientific and Technological Research National Fund for Scientific and Technological Development
  • National Institute for Health Research Imperial Biomedical Research Centre
  • UK Research and Innovation Medical Research Council
  • National Heart Lung and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • American Association for the Study of Liver Diseases
  • Novo Nordisk Haemophilia Foundation
  • National Center for Advancing Translational Sciences

Zitieren

APA

Diaz, L. A., Ajmera, V., Arab, J. P., Huang, D. Q., Hsu, C., Lee, B. P., Louvet, A., Thiele, M., Tavaglione, F., Tincopa, M., Pose, E., Adams, L. A., Alazawi, W., Arrese, M., Bataller, R., Duseja, A., Liangpunsakul, S., Lucey, M. R., Mathurin, P., …, & Loomba, R. (2026). An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice. Clinical Gastroenterology and Hepatology, 24(3), 633-645.e4. https://doi.org/10.1016/j.cgh.2025.02.017

Vancouver

Diaz LA, Ajmera V, Arab JP, Huang DQ, Hsu C, Lee BP, et al. An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice. Clinical Gastroenterology and Hepatology. 2026;24(3):633-645.e4. doi:10.1016/j.cgh.2025.02.017

BibTeX
@article{Diaz2026,
  author = {Diaz, Luis Antonio and Ajmera, Veeral and Arab, Juan Pablo and Huang, Daniel Q and Hsu, Cynthia and Lee, Brian P and Louvet, Alexandre and Thiele, Maja and Tavaglione, Federica and Tincopa, Monica and Pose, Elisa and Adams, Leon A and Alazawi, William and Arrese, Marco and Bataller, Ramon and Duseja, Ajay and Liangpunsakul, Suthat and Lucey, Michael R and Mathurin, Philippe and Mellinger, Jessica and Nakajima, Atsushi and Ratziu, Vlad and Reau, Nancy and Rinella, Mary E and Thursz, Mark and Wong, Vincent Wai-Sun and Kamath, Patrick S and Loomba, Rohit},
  title = {An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {3},
  pages = {633--645.e4},
  doi = {10.1016/j.cgh.2025.02.017}
}
Kostenlos starten →